LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewBose acquired SkullcandyMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESG
Open App
ClosedPublished 8 Nov 2022

Silverback /
ARS Pharma

Silverback and ARS Pharma complete merger transaction

Terms
Undisclosed
Stage
Closed
Buy side: Silverback
Buy sideSilverback
Target: ARS Pharma
TargetARS Pharma
Source · 8 Nov 2022
See the source
Buy side: Silverback
Buy sideSilverback
Target: ARS Pharma
TargetARS Pharma
01 / BuyerSilverback
02 / TargetARS Pharma
01

What happened

Silverback completed its merger with ARS Pharma on Nov. 8, 2022. ARS Pharma survived the merger as a wholly owned subsidiary of Silverback.

Silverback changed its name to ARS Pharmaceuticals, Inc. Terms weren't disclosed.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Silverback and ARS Pharma complete merger transaction

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.